Junk DNA affects inherited cancer risk: New research
A new study published in the British Journal of Cancer shows that inherited cancer risk is not only affected by mutations in key cancer...
Half of WHO-recommended policies to reduce chronic diseases are not put into practice
The first analysis of WHO-recommended policies to reduce chronic diseases finds that implementation is slowly improving, but on average just over half get no...
New global survey shows public perceptions of lung cancer
New global survey shows public perceptions of lung cancer and also highlights that people believe that prognoses for the disease are dire, and there...
Preventing ill health key in unlocking longevity dividend
Experts are coming together to discuss importance of preventative health care in preventing ill health to ensure population ageing is a boost for UK...
Dr Richard Torbett is the new ABPI Chief Executive
The Association of the British Pharmaceutical Industry (ABPI) has appointed Dr. Richard Torbett as its new Chief Executive from January 1, 2020. He takes over...
BMA legal action against NHS Property Services over ‘unjustifiable’ fee hikes
The BMA is launching legal action against NHS Property Services (NHSPS) over “unjustifiable” rises in service charges faced by GP practices. Practices leasing their buildings...
Addressing the wellbeing of doctors – new report from GMC
A new report on the wellbeing of doctors commissioned by the General Medical Council (GMC) says that UK health services could be world leaders...
Lack of knowledge about type 2 diabetes risk factors – survey
An international survey published to mark World Diabetes Day shows a lack of knowledge about type 2 diabetes risk factors. The results of the...
Diabetes UK launches new five-year strategy to tackle the diabetes crisis
Reducing the number of people getting type 2 diabetes and gestational diabetes is one of five key outcomes in Diabetes UK’s new five-year strategy...
NICE guidance on cannabis-based medicinal products
The National Institute for Health and Care Excellence has published guidance on cannabis-based medicinal products. The guideline covers prescribing of cannabis-based medicinal products for...
Latest articles
What’s been authorised? UK, Europe, US drug approvals
Pf summarises the UK, Europe and US drug approvals from 20 - 24 Jan 2020. UK The National Institute for Health and Care Excellence published draft...
Digital interventions for behaviour change
New NICE guidance looks at digital interventions for behaviour change and suggests that these interventions such as apps, wearable devices and online programmes and...
Acute aortic dissection is a ‘ticking time bomb’
Safety body calls for earlier recognition of ‘ticking time bomb’ aortic dissection to prevent deaths as its new report reveals that up to half...
Popular articles
NICE rejects Janssen’s Stelara for moderate to severe ulcerative colitis
The National Institute for Health and Care Excellence (NICE) has not recommended ustekinumab, Janssen's Stelara, for treating moderately to severely active ulcerative colitis in...
Meningitis B infant vaccination programme shows 75% drop in cases over three years
Meningitis B infant vaccination programme shows 75% drop in cases over three years, these are the results of one of two independent meningitis B...
AstraZeneca’s Tagrisso▼ (osimertinib) rejected by NICE for use in NHS England
The National Institute for Health and Care Excellence (NICE) has published final guidance that does not recommend AstraZeneca's Tagrisso▼ (osimertinib) for use within NHS...
Integrated commercial deployment in life sciences and other 2020 health trends
Syneos Health explore integrated commercial deployment in life sciences and discuss their new report covering 2020 health trends. Life science leaders aren’t launching with...
What’s been authorised? UK, Europe, US drug approvals
Pf summarises the UK, Europe and US drug approvals from 20 - 24 Jan 2020. UK The National Institute for Health and Care Excellence published draft...